Toto Hølmebakk

  • Consultant
 

Publications 2022

Gorunova L, Boye K, Panagopoulos I, Berner JM, Bjerkehagen B, Hompland I, Lobmaier I, Hølmebakk T, Hveem TS, Heim S, Micci F (2022)
Cytogenetic and molecular analyses of 291 gastrointestinal stromal tumors: site-specific cytogenetic evolution as evidence of pathogenetic heterogeneity
Oncotarget, 13, 508-517
DOI 10.18632/oncotarget.28209, PubMed 35284037

Publications 2021

Hølmebakk T, Boye K (2021)
ASO Author Reflections: How to Identify Patients at Genuinely High Risk of Recurrence from Localized Gastrointestinal Stromal Tumor of the Stomach?
Ann Surg Oncol, 28 (11), 6846-6847
DOI 10.1245/s10434-021-09608-5, PubMed 33687615

Hølmebakk T, Boye K (2021)
Correction to: ASO Author Reflections: How to Identify Patients at Genuinely High Risk of Recurrence from Localized Gastrointestinal Stromal Tumor of the Stomach?
Ann Surg Oncol, 28 (Suppl 3), 873
DOI 10.1245/s10434-021-09939-3, PubMed 33829360

Hølmebakk T, Wiedswang AM, Meza-Zepeda LA, Hompland I, Lobmaier IVK, Berner JM, Stoldt S, Boye K (2021)
Integrating Anatomical, Molecular and Clinical Risk Factors in Gastrointestinal Stromal Tumor of the Stomach
Ann Surg Oncol, 28 (11), 6837-6845
DOI 10.1245/s10434-021-09605-8, PubMed 33651216

Publications 2019

Hølmebakk T, Bjerkehagen B, Lobmaier IVK, Hompland I, Stoldt S, Boye K (2019)
Is Peritoneal Tumor Penetration of Prognostic Importance in Gastrointestinal Stromal Tumors?
Ann Surg Oncol, 26 (13), 4730-4736
DOI 10.1245/s10434-019-07813-x, PubMed 31520212

Hølmebakk T, Boye K (2019)
Author response to comment on: Relationship between R1 resection, tumour rupture and recurrence in resected gastrointestinal stromal tumour
Br J Surg, 106 (8), 1102-1103
DOI 10.1002/bjs.11245, PubMed 31260582

Hølmebakk T, Nishida T, Rutkowski P, Raut CP (2019)
Defining Rupture in Gastrointestinal Stromal Tumor: Semantics and Prognostic Value
Ann Surg Oncol, 26 (7), 2304-2305
DOI 10.1245/s10434-019-07439-z, PubMed 31076929

Nishida T, Hølmebakk T, Raut CP, Rutkowski P (2019)
Defining Tumor Rupture in Gastrointestinal Stromal Tumor
Ann Surg Oncol, 26 (6), 1669-1675
DOI 10.1245/s10434-019-07297-9, PubMed 30868512

Publications 2018

Boye K, Berner JM, Hompland I, Bruland ØS, Stoldt S, Sundby Hall K, Bjerkehagen B, Hølmebakk T (2018)
Genotype and risk of tumour rupture in gastrointestinal stromal tumour
Br J Surg, 105 (2), e169-e175
DOI 10.1002/bjs.10743, PubMed 29341147

Hompland I, Hølmebakk T, Boye K, Stoldt S, Bjerkehagen B, Berner JM, Wiedswang AM, Revheim ME, Poulsen JP, Hall KS, Bruland ØS (2018)
[Not Available]
Tidsskr Nor Laegeforen, 138 (15)
DOI 10.4045/tidsskr.18.0200, PubMed 30277049

Hølmebakk T (2018)
ASO Author Reflections: The Significance of Tumor Rupture in Gastric Gastrointestinal Stromal Tumors
Ann Surg Oncol, 25 (Suppl 3), 928-929
DOI 10.1245/s10434-018-6881-z, PubMed 30327974

Hølmebakk T, Bjerkehagen B, Hompland I, Stoldt S, Boye K (2018)
Relationship between R1 resection, tumour rupture and recurrence in resected gastrointestinal stromal tumour
Br J Surg, 106 (4), 419-426
DOI 10.1002/bjs.11027, PubMed 30507040

Hølmebakk T, Hompland I, Bjerkehagen B, Stoldt S, Bruland ØS, Hall KS, Boye K (2018)
Recurrence-Free Survival After Resection of Gastric Gastrointestinal Stromal Tumors Classified According to a Strict Definition of Tumor Rupture: A Population-Based Study
Ann Surg Oncol, 25 (5), 1133-1139
DOI 10.1245/s10434-018-6353-5, PubMed 29435684

Stormorken AT, Berg T, Norum OJ, Hølmebakk T, Aaberg K, Steigen SE, Grindedal EM (2018)
APC mosaicism in a young woman with desmoid type fibromatosis and familial adenomatous polyposis
Fam Cancer, 17 (4), 539-543
DOI 10.1007/s10689-018-0072-8, PubMed 29368261

Publications 2017

Hompland I, Bruland ØS, Hølmebakk T, Poulsen JP, Stoldt S, Hall KS, Boye K (2017)
Prediction of long-term survival in patients with metastatic gastrointestinal stromal tumor: analysis of a large, single-institution cohort
Acta Oncol, 56 (10), 1317-1323
DOI 10.1080/0284186X.2017.1330555, PubMed 28557540

Publications 2016

Hølmebakk T, Bjerkehagen B, Boye K, Bruland Ø, Stoldt S, Sundby Hall K (2016)
Definition and clinical significance of tumour rupture in gastrointestinal stromal tumours of the small intestine
Br J Surg, 103 (6), 684-691
DOI 10.1002/bjs.10104, PubMed 26988241

Publications 2011

Hølmebakk T, Solbakken A, Mala T, Nesbakken A (2011)
Clinical prediction of survival by surgeons for patients with incurable abdominal malignancy
Eur J Surg Oncol, 37 (7), 571-5
DOI 10.1016/j.ejso.2011.02.009, PubMed 21444178

Publications 2010

Hølmebakk T, Frykholm G, Viste A, Norwegian Gastrointestinal Cancer Group (NGICG) (2010)
Introducing national guidelines on perioperative chemotherapy for gastric cancer in Norway: a retrospective audit
Eur J Surg Oncol, 36 (7), 610-6
DOI 10.1016/j.ejso.2010.05.006, PubMed 20627647

Publications 2009

Frich L, Hølmebakk T (2009)
Letter 2: Randomized clinical trial of antibiotic therapy versus appendicectomy as primary treatment of acute appendicitis in unselected patients (Br J Surg 2009; 96: 473-481)
Br J Surg, 96 (10), 1224-5
DOI 10.1002/bjs.6851, PubMed 19787749

Publications 2006

Hølmebakk T, Wiig JN, Wanderås EH, Harbitz TB (2006)
[Protective silicone prosthesis prior to radiotherapy of recurrent colonic cancer]
Tidsskr Nor Laegeforen, 126 (4), 447-9
PubMed 16477282

Publications 2005

Hølmebakk T, Nesbakken A (2005)
Surgery for pilonidal disease
Scand J Surg, 94 (1), 43-6
DOI 10.1177/145749690509400111, PubMed 15865116

Publications 2003

Hølmebakk T, Nesbakken A (2003)
Operasjon for sinus pilonidalis sårinfeksjoner, tilhelingstid, residiv og kosmetisk resultat
In Vitenskapelige forhandlinger, Norsk kirurgisk forening., [Oslo], 2003, Abstrakt 72
BIBSYS 041733290

Hølmebakk T, Nesbakken A (2003)
Fra åpen til laparoskopisk appendektomi: gevinster og tap
In Vitenskapelige forhandlinger, Norsk kirurgisk forening., [Oslo], 2003, Abstrakt 92
BIBSYS 041733363

Page visits: 539